Ultrasonic endovascular catheter

Information

  • Patent Grant
  • 10758256
  • Patent Number
    10,758,256
  • Date Filed
    Thursday, December 22, 2016
    8 years ago
  • Date Issued
    Tuesday, September 1, 2020
    4 years ago
Abstract
A catheter includes a wave guide for transmitting ultrasonic energy from a transducer, and which is also rotated to facilitate enhanced disruption of the concerned obstruction in a transverse direction. Embodiments of waveguide include distal anchors that help focus the energy transmitted to a treatment site, and may also include a deployable filter that may open distal of the obstruction to capture any dislodged debris. Selectively inflatable balloons may cordon off a treatment site, and the wave guide may comprise a tube that may serve the dual purposes of inflating the balloon(s), as well as to transmit ultrasonic energy to an obstruction. A portion of an ultrasonic catheter may include plural curved portions to space an exposed portion of the wave guide away from the catheter body to enhance the vibratory action provided.
Description
TECHNICAL FIELD

This document relates generally to the art of endovascular procedures and, more particularly, to an endovascular catheter using ultrasonic energy to perform a medical procedure, such as an atherectomy or thrombectomy.


BACKGROUND

Ultrasonic catheters have been proposed. An example of such a catheter is shown in U.S. Pat. No. 7,540,852, the disclosure of which is fully incorporated herein by reference. While this catheter achieves the desired result of providing enhanced disruption of blood vessel obstructions, the present disclosure proposes certain modifications or improvements to enhance the results achieved during an endovascular procedure in terms of clearing an obstruction from a vessel (such as, for example, an atherectomy for removing atherosclerosis from a blood vessel or or a thrombectomy for dissolving a thrombus or embolus).


SUMMARY

Summarizing the disclosure, an improved ultrasonic catheter for enhancing an endovascular procedure, such as an atherectomy or thrombectomy. The catheter may include a wave guide for transmitting ultrasonic energy from a transducer, and which is also rotated by a motor to facilitate enhanced disruption of the concerned obstruction in a transverse direction. Embodiments of waveguide include distal anchors that help prevent movement of the distal end, and may also include a deployable filter that may open distal of the obstruction to capture any dislodged debris (which may be suctioned out through a lumen in an associated catheter body).


To help improve the treatment regimen, an ultrasonic catheter may also be provided with barriers, such as inflatable balloons, to cordon off a treatment site. In any embodiment including one or more balloons, the waveguide may serve the dual purposes of inflating the balloon(s), as well as transmitting ultrasonic energy to an obstruction. To further enhance the energy transmission for treatment purposes, a portion of the ultrasonic catheter may include one or more curves (possibly selectively actuated by way of a remote control) in order to space an exposed portion of the wave guide away from the catheter body to thereby enhance the vibratory action provided.


According to a first specific aspect of the disclosure, an apparatus for performing an endovascular procedure is provided. The apparatus comprises a catheter and an associated wave guide having a distal end portion adapted for extending from the lumen of the catheter. An actuator for vibrating and rotating the wave guide is also provided.


In one embodiment, the actuator comprises an ultrasonic transducer for vibrating the wave guide and a motor for rotating the ultrasonic transducer or the wave guide. The catheter may include a lumen for receiving a proximal portion of the wave guide, which may include a distal portion having at least one curve or bend. A connector connected to the catheter may at least partially include the actuator, and a controller may be provided for controlling the amount and direction of rotation of the wave guide.


According to a further aspect of the disclosure, an apparatus for performing an endovascular procedure comprises a catheter and a wave guide associated with the catheter. The wave guide includes a distal end with an anchor for anchoring the wave guide. An actuator is also provided for vibrating the wave guide.


In one embodiment, the anchor comprises a centering coil. In another embodiment, the anchor comprises one or more weights. In still another embodiment, the anchor comprises an anchoring cone, and in another is an inflatable balloon. The wave guide may comprise a wire.


Still a further aspect of the disclosure pertains to an apparatus for performing an endovascular procedure. The apparatus comprises a catheter and a wave guide associated with the catheter. The wave guide includes a distal end having a filter with an open end facing a proximal end of the wave guide. An actuator is also provided for vibrating the wave guide.


In one embodiment, the filter comprises a deployable frame supporting a flexible material. The deployable frame may comprise a shape memory material. The flexible material may comprise a porous mesh or similar material for performing a filtering function.


Yet a further aspect of the disclosure pertains to an apparatus for performing an endovascular procedure. The apparatus comprises a catheter including a lumen and supporting a first inflatable balloon. A wave guide includes a distal end portion projecting from the lumen proximally of the first inflatable balloon. An actuator is provided for actuating the wave guide.


In one embodiment, the wave guide comprises a tube for supplying inflation fluid to the first balloon. The apparatus may further include a second balloon, and the wave guide may comprise a wire extending between the first and second balloons. A portion of the catheter between the first and second balloons may comprise one or more openings for transmitting fluid to or from a portion of a vessel bounded by the first and second balloons when inflated.


Another aspect of the disclosure pertains to an apparatus for performing an endovascular procedure. The apparatus comprises a catheter including a lumen extending along a proximal end portion and a distal end portion. A wave guide includes a first portion positioned within the lumen, a second exposed portion, and a third portion connected to the distal end portion of the catheter. An actuator is provided for vibrating at least the second exposed portion of the wave guide.


In a further aspect, the disclosure pertains to an apparatus for performing an endovascular procedure. The apparatus comprises a catheter including a proximal end portion including a lumen and opposed portions. A wave guide includes a first portion positioned within the lumen and a second exposed portion positioned along the opposed portions of the catheter.


In one embodiment, an actuator is provided for vibrating the wave guide. The catheter may also include opposed curved portions. The wave guide may be positioned in a gap or space between the opposed curved portions, which may surround the wave guide (e.g., core wire or tube).


Yet another aspect of the disclosure pertains to an apparatus for performing an endovascular procedure. A catheter supports a first inflatable balloon. A wave guide is associated with the catheter and includes a lumen. An actuator, such as an ultrasonic transducer, is provided for coupling to a proximal end of the wave guide.


In one embodiment, the apparatus further includes a second inflatable balloon supported by the tube proximally of the first inflatable balloon. A tip may also be provided for sealing a distal end of the tube. The tip may include a guidewire lumen.





BRIEF DESCRIPTION OF THE DRAWING FIGURES

The accompanying drawing figures incorporated herein and forming a part of the specification, illustrate several aspects of the ultrasonic endovascular catheter and, together with the description, serve to explain certain principles thereof. In the drawing figures:



FIG. 1 is a schematic view of a prior art catheter system including an ultrasonic catheter;



FIG. 2 is a side view illustrating a general layout of a prior art catheter;



FIG. 3 is a partially cross-sectional, partially cutaway view of a catheter including an ultrasonic wave guide;



FIG. 4 is a partially cutaway, schematic view illustrating an actuator for both vibrating and rotating the wave guide;



FIGS. 5 and 6 are views illustrating the wave guide including different curved portions for moving in the transverse direction to enhance the treatment provided in terms of dissolving an obstruction in a vessel receiving the wave guide;



FIGS. 7, 8, and 9 are side views illustrating various anchors placed at a distal end portion of an ultrasonic wave guide;



FIGS. 10, 11, and 12 are side views of various filters placed at a distal end portion of an ultrasonic wave guide;



FIGS. 13, 14 and 15 illustrate an embodiment of an ultrasonic catheter including first and second inflatable balloons for isolating a treatment site to be treated by an exposed portion of a wave guide;



FIGS. 16 and 17 schematically illustrated another ultrasonic catheter including a tube that may transmit ultrasonic energy and also serve to inflate one or more associated balloons; and



FIG. 18 illustrates still a further embodiment of an ultrasonic catheter including a plurality of curved portions spaced from a wave guide for transmitting energy to a treatment site.





Reference will now be made in detail to the presently disclosed embodiments of the inventive aspects of the ultrasonic endovascular catheter, examples of which are illustrated in the accompanying drawing figures.


DETAILED DESCRIPTION

Ultrasound or ultrasonic catheters provide for disruption of occlusions in blood vessels, such as for example, plaques, clots, lesions, or like objects that hinder blood flow. Catheters generally include a catheter body (shaft), an ultrasonic energy transmission member disposed within the catheter body and a distal head coupled with the energy transmission member and disposed at or near the distal end of the catheter body. The ultrasonic wave guide transmits ultrasonic energy from an ultrasonic transducer to the distal end of the catheter, causing it to vibrate and, thus, disrupt dissolve, or debulk vascular occlusions (which procedures are generally called atherectomies or thrombectomies). A number of improved features of such an ultrasonic catheter are outlined more fully in the following description.


Referring now to FIG. 1, one embodiment of an ultrasonic catheter system 20 includes an ultrasound or ultrasonic catheter 10 and an energy source 16 (which may comprise an ultrasonic generator). Catheter 10 includes a distal end 26 for disrupting occlusions, a catheter shaft or body 27, and a proximal connector 12 for coupling catheter 10 with an ultrasonic transducer 14. Ultrasonic transducer 14 is coupled with source 16 via a connector 28, and generator is coupled with a control, such as a foot-actuated on/off switch 18 via another connector 29. Source 16 provides energy to transducer 14 and, thus, to ultrasonic catheter 10.


Catheter 10 further includes an ultrasonic wave guide (or “core wire”—not shown in FIG. 1) that extends through the catheter body 27 and transmits energy from the transducer 14 to the distal end 26. Some embodiments of catheter 10 include a guidewire, which in FIG. 1 is shown as a so-called “rapid exchange” guidewire 13 and guidewire port, while other embodiments include a proximal guidewire port for over the wire guidewire delivery. In some embodiments, transducer 14 further includes a coupler 15 for coupling the catheter 10 to transducer 14. Connectors 28, 29 may comprise an electric cord or cable or any other suitable connecting devices for coupling on/off switch 18, source 16 and transducer 14. In an alternative embodiment, on/off switch 18 is located on source 16.


In addition to proximal connector 12, ultrasonic catheter 10 may include one or more other various components, such as a Y-connector 11 including a fluid inlet port 17 (or aperture) for passage of irrigation fluid. Inlet port 17 may be removably coupled with an irrigation tube 24, which in one embodiment may be coupled with a fluid refrigerator 30. The refrigerator 30 may, in turn, be coupled with a fluid container 32 via a connector tube 34. This arrangement may be used for introducing one or more fluids into catheter 10. Fluid may be used to cool any part of the device, such as the ultrasonic wave guide, thus helping reduce wear and tear on the catheter 10. In some embodiments, fluid inlet port 17 is located farther proximally on proximal connector 12, to allow fluid to be applied within connector 12. In some embodiments, refrigerated fluid is used, while in other embodiments irrigation fluid may be kept at room temperature. In various embodiments, oxygen supersaturated fluid, lubricious fluid, or any other suitable fluid or combination of fluids may be used, and again, such fluids may be refrigerated or kept room temperature. In an alternative embodiment to that shown in FIG. 1, refrigerator 30 and fluid container 32 are combined in one unit.


Generally, catheter 10 may include any suitable number of side-arms or ports for passage of a guidewire, application of suction, infusing and/or withdrawing irrigation fluid, dye and/or the like, or any other suitable ports or connections. Also, ultrasonic catheters 10 per the disclosure may be used with any suitable proximal devices, such as any suitable ultrasonic transducer 14, energy source 16, coupling device(s) and/or the like. Therefore, the exemplary embodiment shown in FIG. 1 and any following descriptions of proximal apparatus or systems for use with ultrasonic catheters 10 should not be interpreted to limit the scope of the appended claims.


Referring now to FIG. 2, an enlarged view of catheter 10 is shown. Proximal connector 12, Y-connector 11, inlet port 17, catheter body 27, distal end 26 and guidewire 13 are all shown. Catheter body 27 is generally a flexible, tubular, elongate member, having any suitable diameter and length for reaching a vascular occlusion for treatment. In one embodiment, for example, catheter body 27 preferably has an outer diameter of between about 0.5 mm and about 5.0 mm. In other embodiments, as in catheters intended for use in relatively small vessels, catheter body 27 may have an outer diameter of between about 0.25 mm and about 2.5 mm. Catheter body 27 may also have any suitable length. As discussed briefly above, for example, some ultrasonic catheters have a length in the range of about 150 cm. However, any other suitable length may be used without departing from the scope of the present disclosure.


Referring now to FIG. 3, a proximal portion of one embodiment of an ultrasonic catheter 110 is shown in cross-section. An ultrasonic wave guide 140 extends from a sonic connector 152 distally to a distal end (not shown) of catheter 110. A catheter body 127 of catheter 110 is shown only in part, whereas catheter body typically extends distally to (or near) the distal end of catheter 110, with the wave guide 140 also extending a particularly long distance (e.g., 30 centimeters or greater, and typically between about 15 centimeters and 30 centimeters). The catheter body 127 may be a constant diameter, or may have a variable diameter from the proximal to the distal end (such as, for example, wider in diameter at the proximal end near the point of entering the vasculature than at the distal end, where the vessel is narrower)


Catheter 110 also includes a proximal housing 112 (or “proximal connector”), having an inner bore 144 (or “inner cavity”) in which sonic connector 152, a portion of ultrasonic wave guide 140 and one or more vibration absorbers 150 reside. Housing 112 is coupled with a Y-connector 111, which includes a fluid inlet port 117 (or aperture), and Y-connector 111 is coupled with catheter body 127.


In various embodiments, housing 112 may suitably include one or more surface features 142 for increasing the overall surface area of the outer surface of housing 112. Increased surface area enhances the ability of housing 112 to dissipate heat generated by ultrasonic wave guide 140 out of catheter 110. Surface features 142 may have any suitable size or shape, such as ridges, jags, undulations, grooves or the like, and any suitable number of surface features 142 may be used. Additionally, housing 112 may be made of one or more heat dissipating materials, such as aluminum, stainless steel, any other conductive metal(s), or any suitable non-metallic conductive material(s).


In most embodiments, ultrasonic wave guide 140, such as wire, extends longitudinally through a lumen of catheter body 127 to transmit ultrasonic energy from an ultrasonic transducer 14 (not shown in FIGS. 2 and 3), connected to the proximal end of proximal housing 112, to the distal end of catheter 110. Wave guide 140 may be formed of any material capable of effectively transmitting ultrasonic energy from the ultrasonic transducer 14 to the distal end of catheter body 127, including but not limited to metals such as pure titanium or aluminum, titanium or aluminum alloys, or shape memory materials (such as nitinol), and may be coated (such as using a polymeric material). Again, additional details of ultrasonic wave guides 140 may be found in the patent applications incorporated by reference. Similarly, reference may be made to the incorporated patent applications for descriptions of housing 112, sonic connector 152, vibration absorbers 150, Y-connector 111 and the like. For example, housing 112 and other features are described in detail in Ser. No. 10/722,209, filed Nov. 24, 2003, entitled “Steerable Ultrasound Catheter,” incorporated herein by reference.


Ultrasonic wave guide 140 typically passes from a sonic connector 152, through bore 144 and Y-connector 111, and then through catheter body 127. Fluid inlet port 117 is in fluid communication with a lumen in Y-connector, which is in fluid communication with a lumen extending through catheter body 127. Thus, fluid introduced into fluid inlet port 117 is typically free to flow into and through catheter body 127 to contact ultrasonic wave guide 140. Fluid may flow out of catheter body 127 through apertures in the distal head (not shown) or through any other suitable apertures or openings, such as apertures located in catheter body 127 itself. Any suitable fluid may be passed through fluid inlet port 117 and catheter body 127, such as refrigerated fluid, lubricious fluid, super-saturated saline or contrast/saline mixture, or the like. Cooling and/or lubricating ultrasonic wave guide 140 may reduce friction and/or wear and tear of ultrasonic wave guide 140, thus prolonging the useful life of ultrasonic catheter 110 and enhancing its performance.


Referring now to FIG. 4, the wave guide 140 or wire may employ an actuator that both vibrates the wave guide through the application of ultrasonic energy, such as from transducer 14, and also causes it to rotate about its longitudinal axis X, such as through the application for rotational motion to the transducer or any structure connected to the wave guide. In one embodiment, this may be achieved by providing an integral, rotary motor 154 as part of the ultrasonic transducer 14 (which may include the sonic connector 152 therein, or the wave guide 140 may be crimped directly onto the horn of the transducer). Power for the motor 154 may be supplied by a pair of wires 156, 158 (one to ground, one to positive) for causing relative rotation of the wave guide 140. Wires 156, 158 may be connected to an energy source, such as a power supply 160 for powering both the motor 154 and the transducer 14 (but separate sources could be used, including for example, integral batteries to avoid the need for external wires).


As illustrated, the wires 156, 158 if present may be twisted to allow for the relative rotation without creating binding problems. The rotation of the wave guide 140 may be continuous in one direction, or may be bi-directional (including a rotation of less than 360 degrees in each direction, such that the wave guide may be caused to oscillate about the longitudinal axis X). Control of the rotation may be provided by an associated controller 159 for controlling the power supply 160, which may reverse the flow of current to the motor 154 according to a pre-programmed operation or as a result of manual control provided by a clinician to control the relative direction and amount of rotation. Using the controller 159, the rotation may also be selectively turned on and off, while the vibratory energy is on, or the rotation may be provided while the vibratory energy is turned off.


As indicated in FIGS. 5 and 6, the wave guide 140 may also be provided with a curved portion C, which may include a single curve (FIG. 5) or multiple curves (FIG. 6). The curved portions C extend in the transverse direction T and thus are spaced from the axis X. Thus, causing the wave guide 140 to rotate (arrow R) using motor 154 or otherwise rotating it via an imparted external force, creates movement in the transverse direction T. Combined with the vibration created by the ultrasonic energy transmitted from transducer 14, the wave guide 140 may thus serve to engage and clear an obstruction, such as a plaque, lesion or thrombus/embolus, when positioned in a blood vessel and associated with connector 112 of catheter 110. The catheter body 127 may also be advanced in the vessel and suction applied (such as through port 117) to aspirate any dislodged material (which may be done using a two part telescoping catheter body, such that one part remains connected to connector 112 and another part advances and retracts relative to the connected part).


Turning now to FIGS. 7-9, a further aspect of the disclosure is illustrated in several embodiments. In these embodiments, the wave guide 140 is provided with an anchor 180 at a distal end thereof, which may include a tip 141. This anchor serves to hold the distal end of the wave guide at a centered location within the vessel, and preclude it from moving in a transverse direction T.


In the FIG. 7 embodiment, the anchor 180 is shown as including a coil 182 having a radial extent that is substantially greater than the diameter of the wave guide 140 for engaging the interior walls of the blood vessel. The coil 182 may have a single loop or multiple loops, as shown. As noted above, the wave guide 140 may also be provided with an initially straight configuration (such as for passing into or through an obstruction, such as a thrombus), and as a result of a shape memory material, be caused to assume the coiled configuration in situ as a result of a temperature change (such as by a refrigerated fluid). The coil 182 may also have a conical configuration with a relatively tight coil, and may thus function as a filter for capturing any dislodged material during the endovascular procedure.


Alternatively or additionally, the FIG. 8 embodiment shows that the anchor 180 takes the form of one or more weights 184 positioned proximally of the tip 141. These weights 184 may be in the form of balls (which may be generally spherical), and thus serve to hold the distal end of the wave guide 140, and preclude it from moving in a transverse direction T. As illustrated, the tip 141 may also optionally comprise a weight 184. The extended length of section 140c may be controlled by advancing or retracting catheter body 127.


For the embodiment of FIG. 9, the anchor 180 comprises an anchoring cone 186, which may have circumferentially spaced radial extensions 186a for engaging the vessel walls to provide a centering function, and again transmitting the ultrasonic energy locally to the proximal portion 140c of the wave guide 140. As with the FIG. 7 embodiment, the cone 186 may also be provided with an initially relaxed configuration for insertion, and as a result of a shape memory material, be caused to assume the deployed configuration in situ as a result of a temperature change (such as by a refrigerated fluid).


This embodiment further illustrates that the cross-section of the wave guide 140 may be locally increased, such as by creating a spherical ball 188 therein. This helps to ensure that the wave guide 140 does not disconnect from the anchor 180 as a result of the foreshortening and lengthening creating during the application of vibratory energy. Multiple balls 188 may also be provided, such as one distal of the anchor 180 and one proximal of the anchor. The balls 188 may be generally spherical, and a distal ball provided at tip 141 may be made by melting the material of the wave guide 140.


Turning now to FIGS. 10, 11 and 12, it can also be appreciated that a distal end of the wave guide 140 may be provided with a filter 190, which may be initially collapsed for passing through a thrombus B in a vessel V via a soft tip 191. In the illustrated embodiment, the filter 190 when expanded (such as by using a shape memory material) includes an open proximal end 12 and a body 194 comprising a filtering material, such as a fine mesh, cage, or the like. Thus, when the wave guide 140 is ultrasonically vibrated, any particles loosened from the obstruction (e.g., thrombus B) as a result may travel distally through the open end of the filter 190 and be captured by the body 194 for later removal once the procedure is completed. To remove any captured particles or objects, the filter 190 may be collapsed, such as using an external sheath 193 (which may also provide suction via a provided port to withdraw any dislodged material).



FIGS. 11 and 12 illustrate a specific example of a filter 190, which may comprise a body 194 including an expandable frame 196 (again, using a shape memory material) supporting a flexible or foldable material 198, such as a fabric, film (such as, for example, a porous polymer film), or the like. The frame 196 when expanded may form a conical structure having an open proximal end 192 oriented similarly as in FIG. 10 and a closed distal end. The material 198 connected to the frame forms a basket for capturing dislodged particles created from the vibration of the wave guide 140. As illustrated, the filter 190 may be connected to the wave guide 140 by tethers 196a, which may also form part of the frame 196, and thus the wave guide may also transmit vibratory energy to the filter 190. To remove any captured particles or objects, the filter 190 may be collapsed, such as by using temperature control to return the shape memory material to its original state during insertion.


A further embodiment of an ultrasonic catheter 200 is illustrated with reference to FIGS. 13 and 14. In this embodiment, the catheter body 127 supports a plurality of inflatable balloons. Specifically, a first balloon 202 is positioned adjacent a distal end of the body 127, and a second balloon 204 is positioned proximally of the first balloon. The balloons 202, 204 may be inflated via a dual or coaxial inflation lumen 128 provided in the catheter body 127, which may include inlets 128a located in and communicating with the interior compartment of each balloon. Lumen 128 may receive inflation fluid from the fluid inlet port 117. When inflated, the balloons 202, 204 thus serve to anchor the catheter 200 at a treatment site, and also isolate a portion of the site for undergoing treatment.


The catheter body 127 may also include a second lumen 129 for receiving the wave guide 140. This second lumen 129 allows for an exposed portion to exit and pass external to the body 127 along a distal portion thereof, and ultimately re-enter the body at a point distal of the exit point, but proximal of the first distal balloon 202. To avoid interfering with the ultrasonic vibration of the wave guide 140, a corresponding portion 127a of the catheter body 127 may be non-linear or curved, and thus spaced from the wave guide 140, but could optionally be straight or partially curved.


A third lumen 130 in the body 127 may communicate with openings 130a in the portion 127a of the catheter body 127 intermediate the balloons 202, 204. These openings 130a may be used to withdraw fluid from a vessel when the body 127 is inserted therein, such as through a fluid port 118 associated with the connector 112. Alternatively, the openings 130a via lumen 130 or may be used to deliver substances to the vessel, such as, for instance, thrombolytic agents (such as, for example, Eminase (anistreplase) Retavase (reteplase) Streptase (streptokinase, kabikinase) t-PA (class of drugs that includes Activase) TNKase (tenecteplase) Abbokinase, Kinlytic (rokinase), or others). The body 127 may also optionally include a guidewire lumen 131 for receiving a guidewire 13, but use of a rapid-exchange configuration as described above is also possible.


In use, the wave guide 140 as a result of the advancement of the catheter body 127 may pass through or adjacent the obstruction in a vessel, such as thrombus B. The balloons 202, 204 may be inflated in the vessel being treated to concurrently anchor the catheter 200, which as can be appreciated serves to isolate a portion of the vessel including the obstruction (thrombus B). Substances such as thrombolytic agents may then be optionally delivered to the isolated portion of the vessel under treatment via port 118, lumen 130, and openings 130a to aid in dissolving the obstruction, and concurrently (or not), the wave guide 140 may be used to deliver ultrasonic energy to further assist in clearing the obstruction.


With the balloons 202, 204 remaining inflated, it can also be appreciated that the openings 130a may be used to remove material (including fluid) from the isolated portion of the vessel, such as by applying appropriate suction to the port 118. This may be done after a suitable amount of time has passed to ensure that any agents introduced have had time to act on the obstruction. When the obstruction is reduced or removed, the balloons 202, 204 may be deflated and the catheter body 127 moved along guidewire 13 as desired for removal or further treatment at an alternate location.


A further embodiment of an ultrasonic catheter 300 is shown in FIGS. 16 and 17, which includes a catheter body 127. In FIG. 16, the wave guide 140 comprises a tube 302, rather than a solid wire. This tube 302 which may be used to transmit ultrasonic energy from a transducer 14 to an obstruction, such as thrombus B (or thrombi). The distal end 302a of the tube 302 serving as wave guide 140 may be capped by an atraumatic tip 304, which may be used to move the tube 302 through the thrombus B (or thrombi). The tip 304 may also include a guidewire lumen 304a for guiding the tube 302 along a guide wire (not shown), which may be associated with a lumen in the catheter body 127 (see, e.g., FIG. 14).


In one particular embodiment, the tube 302 is adapted to inflate a balloon 306. The balloon 306 may be supported on the tube 302 proximally of the tip 304. The inflation fluid for inflating the balloon 306 may flow through the tube 302 via a proximal port (not shown). The fluid may exit the tube 302 to the interior compartment of the balloon via a port 302b.


In use, the catheter 300 may be partially passed through the obstruction (thrombus or thrombi) using tip 304 to extend the tube 302 therethrough, and the balloon 306 inflated. The transducer 14 may be activated to transmit energy to the obstruction to disrupt or dislodge it, with any dislodged particles or material being aspirated through the catheter body 127 (see arrows A). Additionally or alternatively, any thrombolytic agents may be delivered via the catheter body 127 to the treatment site prior to or during the tube activation to facilitate dissolving the obstruction, with any such substances remaining at the introduction site in view of the distal blockage created when the balloon 306 is inflated. When the procedure is complete, the balloon 306 may be deflated using the port 302b, and the catheter 300 moved accordingly.



FIG. 17 further illustrates that a second, proximal balloon 308 may also be provided on the ultrasonic catheter 300, which may likewise be inflated using a port 302c in tube 302 (such as using a coaxial or dual lumen). The balloons 306, 308 may thus be inflated on either side of the obstruction to isolate it. Wave guide 140 may be activated as desired to disrupt the obstruction. Ports or openings 302d may also be provided in the tube 302 for aspirating debris or introducing treatment agents, with corresponding lumens (not shown) provided in the tube as necessary for this purpose (see, e.g., multi-lumen catheter body 127 in FIG. 14). Alternatively, once the obstruction is cleared, the proximal balloon 308 may be deflated and the body 127 used to aspirate any dislodged material.


Turning now to FIG. 18, a further embodiment of an ultrasonic catheter 500 is shown. In this embodiment, the catheter body 127 may include one or more curved portions, such as two curved portions 127a, that are spaced in a transverse direction T from the wave guide 140. In the illustrated embodiment, the portions 127a are symmetrical about the longitudinal axis X and curved in opposition to each other (relative to a central longitudinal axis of the catheter). These portions 127 thus provide a centering function for the wave guide 140, which may be exposed in a space between the portions 127a for transmitting ultrasonic energy from an associated transducer 14 to a treatment site. The wave guide 140 may also extend to and possibly through a distal tip of the catheter body 127, and may be connected to it.


In summary, improved ultrasonic catheters 110, 200, 300, 500 are disclosed. In one example, the catheter 110 includes a wave guide 140 for transmitting ultrasonic energy from a transducer 14, and which is also rotated by a motor 154 to facilitate enhanced disruption of the concerned obstruction in a transverse direction. Embodiments of waveguide 140 include distal anchors 180 to restrain a corresponding portion of the waveguide, and may also include a deployable filter 190 that may open distal of the obstruction to capture any dislodged debris (which may be aspirated by the catheter body 127, including by advancing it). An embodiment of an ultrasonic catheter 200 is also disclosed that includes selectively inflatable balloons 206, 208 to cordon off a treatment site, as well as an embodiment in which the waveguide 104 comprises a tube 302 that may serve the dual purposes of inflating an associated balloon 306 (or balloons 306, 308), as well as to transmit ultrasonic energy to an obstruction. Still a further embodiment of a catheter 500 comprises a plurality of curved portions 127a spaced from a wave guide 140.


The foregoing description has been presented for purposes of illustration. It is not intended to be exhaustive or to limit the embodiments to the precise form disclosed. Obvious modifications and variations are possible in light of the above teachings. All modifications and variations are within the scope of the appended claims when interpreted in accordance with the breadth to which they are fairly, legally and equitably entitled.

Claims
  • 1. An apparatus for performing an endovascular procedure, comprising: a catheter body including a lumen extending along a proximal end portion and a distal end portion, the catheter body having at the distal end portion opposed portions, the proximal end portion being positioned along a central longitudinal axis;an ultrasonic wave guide including a first portion positioned within the lumen and a second exposed portion, wherein the opposed portions at the distal end portion of the catheter body are spaced directly across the central longitudinal axis and are spaced in a transverse direction from the central longitudinal axis, wherein a gap is defined between the opposed portions, the second exposed portion of the ultrasonic wave guide extends in the gap, each of the opposed portions has an entire length, the opposed portions are reflectively symmetrical about the central longitudinal axis, each opposed portion curves along the central longitudinal axis along the entire length, and wherein the opposed portions provide a centering function for the ultrasonic wave guide at a treatment site; andan ultrasonic transducer coupled to the ultrasonic wave guide for vibrating the ultrasonic wave guide at an ultrasonic frequency.
  • 2. An apparatus for performing an endovascular procedure, comprising: an ultrasonic catheter positioned along a central longitudinal axis, the ultrasonic catheter including a proximal end portion, the proximal end portion including a lumen, and the ultrasonic catheter including opposed portions distal to the proximal end portion, wherein the opposed portions are spaced in a transverse direction from the central longitudinal axis, wherein the opposed portions define a transverse gap; andan ultrasonic wave guide including a first portion positioned within the lumen and a second exposed portion, the ultrasonic wave guide being positioned along the central longitudinal axis, the second exposed portion being exposed in the transverse gap between the opposed portions of the ultrasonic catheter, the second exposed portion extending in the transverse gap between the opposed portions of the ultrasonic catheter,wherein the opposed portions are reflectively symmetrical about the central longitudinal axis, the opposed portions curve along the central longitudinal axis, and wherein the opposed portions provide a centering function for the ultrasonic wave guide at a treatment site.
  • 3. The apparatus of claim 2, further including an actuator having an ultrasonic transducer coupled to the ultrasonic wave guide for vibrating the ultrasonic wave guide at an ultrasonic frequency.
  • 4. The apparatus of claim 2, wherein the opposed portions curve along the central longitudinal axis of the ultrasonic catheter in opposite directions to define the transverse gap.
  • 5. The apparatus of claim 2, wherein an ultrasonic catheter further includes a distal tip through which the ultrasonic wave guide extends.
  • 6. The apparatus of claim 2, wherein an ultrasonic catheter further includes a distal tip, wherein the ultrasonic wave guide extends to the distal tip.
  • 7. The apparatus of claim 2, wherein an ultrasonic catheter further includes a distal tip, wherein the ultrasonic wave guide is connected to the distal tip of the ultrasonic catheter.
  • 8. An apparatus for performing an endovascular procedure, comprising: a catheter body including a lumen extending along a proximal end portion and a distal end portion, the proximal end portion being positioned along a central longitudinal axis, the catheter body having at the distal end portion opposed portions that curve along the central longitudinal axis, the opposed portions comprise a first opposed portion and a second opposed portion, the first opposed portion is spaced across the central longitudinal axis from the second opposed portion, the opposed portions defining a space between;an ultrasonic wave guide including a first portion positioned within the lumen and a second exposed portion, the second exposed portion extending through the space, the ultrasonic wave guide having a total length, wherein the second exposed portion has a second exposed portion entire length, the total length of the ultrasonic wave guide is positioned along the central longitudinal axis, wherein the opposed portions provide a centering function for the ultrasonic wave guide at a treatment site; andan ultrasonic transducer coupled to the ultrasonic wave guide for vibrating the ultrasonic wave guide at an ultrasonic frequency, wherein the opposed portions are reflectively symmetrical about the central longitudinal axis for an entirety of the second exposed portion entire length.
US Referenced Citations (408)
Number Name Date Kind
3296620 Rodda Jan 1967 A
3433226 Boyd Mar 1969 A
3443226 Knight May 1969 A
3565062 Kurls Feb 1971 A
3585082 Siller Jun 1971 A
3612038 Halligan Oct 1971 A
3631848 Muller Jan 1972 A
3679378 Van Impe et al. Jul 1972 A
3719737 Vaillancourt et al. Mar 1973 A
3739460 Addis et al. Jun 1973 A
3754746 Thiele Aug 1973 A
3823717 Pohlman et al. Jul 1974 A
3835690 Leonhardt et al. Sep 1974 A
3839841 Amplatz Oct 1974 A
3896811 Storz Jul 1975 A
4016882 Broadwin et al. Apr 1977 A
4033331 Guss et al. Jul 1977 A
4136700 Broadwin et al. Jan 1979 A
4337090 Harrison Jun 1982 A
4368410 Hance et al. Jan 1983 A
4417578 Banko Nov 1983 A
4425115 Wuchinich Jan 1984 A
4486680 Bonnet et al. Dec 1984 A
4505767 Quin Mar 1985 A
4535759 Polk et al. Aug 1985 A
4545767 Suzuki et al. Oct 1985 A
4565589 Harrison Jan 1986 A
4565787 Bossle et al. Jan 1986 A
4572184 Stohl et al. Feb 1986 A
4664112 Kensey et al. May 1987 A
4665906 Jervis May 1987 A
4679558 Kensey et al. Jul 1987 A
4700705 Kensey et al. Oct 1987 A
4721117 Mar et al. Jan 1988 A
4750902 Wuchinich et al. Jun 1988 A
4808153 Parisi Feb 1989 A
4811743 Stevens Mar 1989 A
4827911 Broadwin et al. May 1989 A
4838853 Parisi Jun 1989 A
4854325 Stevens Aug 1989 A
4870953 DonMicheal et al. Oct 1989 A
4886060 Wiksell Dec 1989 A
4920954 Alliger et al. May 1990 A
4923462 Stevens May 1990 A
4924863 Sterzer May 1990 A
4931047 Broadwin et al. Jun 1990 A
4936281 Stasz Jun 1990 A
4936845 Stevens Jun 1990 A
5000185 Yock Mar 1991 A
5015227 Broadwin et al. May 1991 A
5026384 Farr et al. Jun 1991 A
5030357 Lowe Jul 1991 A
5046503 Schneiderman Sep 1991 A
5053008 Bajaj Oct 1991 A
5058570 Idemoto et al. Oct 1991 A
5076276 Sakurai et al. Dec 1991 A
5091205 Fan Feb 1992 A
5100423 Fearnot Mar 1992 A
5109859 Jenkins May 1992 A
5114414 Buchbinder May 1992 A
5116350 Stevens May 1992 A
5127917 Niederhauser et al. Jul 1992 A
5156143 Bocquet et al. Oct 1992 A
5163421 Bernstein et al. Nov 1992 A
5171216 Dasse et al. Dec 1992 A
5180363 Idemoto et al. Jan 1993 A
5183470 Wettermann Feb 1993 A
5195955 Don Michael Mar 1993 A
5215614 Wijkamp et al. Jun 1993 A
5217565 Kou et al. Jun 1993 A
5221255 Mahurkar et al. Jun 1993 A
5226421 Frisbie et al. Jul 1993 A
5234416 Macaulay et al. Aug 1993 A
5238004 Sahatjian et al. Aug 1993 A
5242385 Strukel Sep 1993 A
5243997 Uflacker et al. Sep 1993 A
5248296 Alliger Sep 1993 A
5255669 Kubota et al. Oct 1993 A
5267954 Nita Dec 1993 A
5269291 Carter Dec 1993 A
5269297 Weng et al. Dec 1993 A
5269793 Simpson Dec 1993 A
5279546 Mische Jan 1994 A
5287858 Hammerslag et al. Feb 1994 A
5290229 Paskar Mar 1994 A
5304115 Pflueger et al. Apr 1994 A
5304131 Paskar Apr 1994 A
5312328 Nita et al. May 1994 A
5318014 Carter Jun 1994 A
5318570 Hood et al. Jun 1994 A
5324255 Passafaro et al. Jun 1994 A
5324260 O'Neill et al. Jun 1994 A
5325860 Seward et al. Jul 1994 A
5326342 Pflueger et al. Jul 1994 A
5328004 Fannin et al. Jul 1994 A
5329927 Gardineer et al. Jul 1994 A
5341818 Abrams et al. Aug 1994 A
5342292 Nita et al. Aug 1994 A
5344395 Whalen et al. Sep 1994 A
5346502 Estabrook et al. Sep 1994 A
5362309 Carter Nov 1994 A
5368557 Nita Nov 1994 A
5368558 Nita et al. Nov 1994 A
5376084 Bacich et al. Dec 1994 A
5378234 Hammerslag et al. Jan 1995 A
5380274 Nita Jan 1995 A
5380316 Aita et al. Jan 1995 A
5382228 Nita et al. Jan 1995 A
5383460 Jang et al. Jan 1995 A
5389096 Aita et al. Feb 1995 A
5391144 Sakurai et al. Feb 1995 A
5397293 Alliger et al. Mar 1995 A
5397301 Pflueger et al. Mar 1995 A
5405318 Nita Apr 1995 A
5409483 Campbell et al. Apr 1995 A
5417672 Nita et al. May 1995 A
5417703 Brown et al. May 1995 A
5421923 Clarke et al. Jun 1995 A
5427118 Nita et al. Jun 1995 A
5431168 Webster, Jr. Jul 1995 A
5431663 Carter Jul 1995 A
5443078 Uflacker Aug 1995 A
5447509 Mills et al. Sep 1995 A
5449369 Imran Sep 1995 A
5451209 Ainsworth et al. Sep 1995 A
5462529 Simpson Oct 1995 A
5465733 Hinohara et al. Nov 1995 A
5474530 Passafaro et al. Dec 1995 A
5474531 Carter Dec 1995 A
5480379 La Rosa Jan 1996 A
5484398 Stoddard Jan 1996 A
5487757 Truckai et al. Jan 1996 A
5498236 Dubrul et al. Mar 1996 A
5507738 Ciervo Apr 1996 A
5516043 Manna et al. May 1996 A
5527273 Manna et al. Jun 1996 A
5540656 Pflueger et al. Jul 1996 A
5542917 Nita et al. Aug 1996 A
5597497 Dean et al. Jan 1997 A
5597882 Schiller et al. Jan 1997 A
5607421 Jeevanandam et al. Mar 1997 A
5611807 O'Boyle Mar 1997 A
5618266 Liprie Apr 1997 A
5626593 Imran May 1997 A
5627365 Chiba et al. May 1997 A
5649935 Kremer et al. Jul 1997 A
5658282 Daw et al. Aug 1997 A
5685841 Mackool Nov 1997 A
5695460 Siegel et al. Dec 1997 A
5695507 Auth et al. Dec 1997 A
5715825 Crowley Feb 1998 A
5720724 Ressemann et al. Feb 1998 A
5728062 Brisken Mar 1998 A
5738100 Yagami et al. Apr 1998 A
5797876 Spears et al. Aug 1998 A
5816923 Milo et al. Oct 1998 A
5827203 Nita Oct 1998 A
5827971 Hale et al. Oct 1998 A
5830222 Makower Nov 1998 A
5846218 Brisken et al. Dec 1998 A
5893838 Daoud et al. Apr 1999 A
5895397 Jang et al. Apr 1999 A
5902287 Martin May 1999 A
5904667 Falwell May 1999 A
5913192 Parthasarathy et al. Jun 1999 A
5916192 Nita et al. Jun 1999 A
5916912 Ames et al. Jun 1999 A
5935142 Hood Aug 1999 A
5935144 Estabrook Aug 1999 A
5937301 Gardner et al. Aug 1999 A
5944737 Tsonton et al. Aug 1999 A
5957882 Nita et al. Sep 1999 A
5957899 Spears et al. Sep 1999 A
5964223 Baran Oct 1999 A
5967984 Chu et al. Oct 1999 A
5971949 Levin et al. Oct 1999 A
5976119 Spears et al. Nov 1999 A
5989208 Nita Nov 1999 A
5989275 Estabrook et al. Nov 1999 A
5997497 Nita et al. Dec 1999 A
6004280 Buck et al. Dec 1999 A
6007499 Martin et al. Dec 1999 A
6007514 Nita Dec 1999 A
6022309 Celliers et al. Feb 2000 A
6024764 Schroeppel Feb 2000 A
6029671 Stevens et al. Feb 2000 A
6030357 Daoud et al. Feb 2000 A
6051010 DiMatteo et al. Apr 2000 A
6113558 Rosenschein et al. Sep 2000 A
6123698 Spears et al. Sep 2000 A
6142971 Daoud et al. Nov 2000 A
6149596 Bancroft Nov 2000 A
6159176 Broadwin et al. Dec 2000 A
6165127 Crowley Dec 2000 A
6165188 Saadat et al. Dec 2000 A
6179809 Khairkhahan et al. Jan 2001 B1
6180059 Divino, Jr. et al. Jan 2001 B1
6190353 Makower et al. Feb 2001 B1
6206842 Tu et al. Mar 2001 B1
6210356 Anderson et al. Apr 2001 B1
6217543 Anis et al. Apr 2001 B1
6217565 Cohen Apr 2001 B1
6217588 Jerger et al. Apr 2001 B1
6221015 Yock Apr 2001 B1
6231546 Milo et al. May 2001 B1
6231587 Makower May 2001 B1
6235007 Divino, Jr. et al. May 2001 B1
6241692 Tu et al. Jun 2001 B1
6241703 Levin et al. Jun 2001 B1
6248087 Spears et al. Jun 2001 B1
6277084 Abele et al. Aug 2001 B1
6283983 Makower et al. Sep 2001 B1
6287271 Dubrul et al. Sep 2001 B1
6287285 Michal et al. Sep 2001 B1
6287317 Makower et al. Sep 2001 B1
6296620 Gesswein et al. Oct 2001 B1
6298620 Hatzinikolas Oct 2001 B1
6302875 Makower et al. Oct 2001 B1
6309358 Okubo Oct 2001 B1
6315741 Martin et al. Nov 2001 B1
6315754 Daoud et al. Nov 2001 B1
6331171 Cohen Dec 2001 B1
6346192 Buhr et al. Feb 2002 B2
6379378 Werneth et al. Apr 2002 B1
6387109 Davison et al. May 2002 B1
6387324 Patterson et al. May 2002 B1
6394956 Chandrasekaran et al. May 2002 B1
6398736 Seward Jun 2002 B1
6409673 Yock Jun 2002 B2
6416533 Gobin et al. Jul 2002 B1
6423026 Gesswein et al. Jul 2002 B1
6427118 Suzuki Jul 2002 B1
6433464 Jones Aug 2002 B2
6434418 Neal et al. Aug 2002 B1
6450975 Brennan et al. Sep 2002 B1
6454757 Nita et al. Sep 2002 B1
6454997 Divino, Jr. et al. Sep 2002 B1
6484052 Visuri et al. Nov 2002 B1
6491707 Makower et al. Dec 2002 B2
6494891 Cornish et al. Dec 2002 B1
6494894 Mirarchi Dec 2002 B2
6500141 Irion et al. Dec 2002 B1
6508781 Brennan et al. Jan 2003 B1
6508784 Shu Jan 2003 B1
6511458 Milo et al. Jan 2003 B2
6524251 Rabiner et al. Feb 2003 B2
6533766 Patterson et al. Mar 2003 B1
6544215 Bencini et al. Apr 2003 B1
6547754 Evans et al. Apr 2003 B1
6551337 Rabiner et al. Apr 2003 B1
6554846 Hamilton et al. Apr 2003 B2
6555059 Myrick et al. Apr 2003 B1
6558502 Divino, Jr. et al. May 2003 B2
6562031 Chandrasekaran et al. May 2003 B2
6573470 Brown et al. Jun 2003 B1
6576807 Brunelot et al. Jun 2003 B1
6582387 Derek et al. Jun 2003 B2
6589253 Cornish et al. Jul 2003 B1
6595989 Schaer Jul 2003 B1
6596235 Divino, Jr. et al. Jul 2003 B2
6602467 Divino, Jr. et al. Aug 2003 B1
6602468 Patterson et al. Aug 2003 B2
6605217 Buhr et al. Aug 2003 B2
6607698 Spears et al. Aug 2003 B1
6610077 Hancock et al. Aug 2003 B1
6613280 Myrick et al. Sep 2003 B2
6615062 Ryan et al. Sep 2003 B2
6616617 Ferrera et al. Sep 2003 B1
6622542 Derek et al. Sep 2003 B2
6623448 Slater Sep 2003 B2
6635017 Moehring et al. Oct 2003 B1
6650923 Lesh et al. Nov 2003 B1
6652547 Rabiner et al. Nov 2003 B2
6660013 Rabiner et al. Dec 2003 B2
6676900 Divino, Jr. et al. Jan 2004 B1
6682502 Bond et al. Jan 2004 B2
6685657 Jones Feb 2004 B2
6689086 Nita et al. Feb 2004 B1
6695781 Rabiner et al. Feb 2004 B2
6695782 Ranucci et al. Feb 2004 B2
6695810 Peacock, III et al. Feb 2004 B2
6702748 Nita et al. Mar 2004 B1
6702750 Yock Mar 2004 B2
6719715 Newman et al. Apr 2004 B2
6719725 Milo et al. Apr 2004 B2
6729334 Baran May 2004 B1
6733451 Rabiner et al. May 2004 B2
6758846 Goble et al. Jul 2004 B2
6761698 Shibata et al. Jul 2004 B2
6855123 Nita Feb 2005 B2
6866670 Rabiner et al. Mar 2005 B2
6936025 Evans et al. Aug 2005 B1
6936056 Nash et al. Aug 2005 B2
6942620 Nita et al. Sep 2005 B2
6942677 Nita et al. Sep 2005 B2
6955680 Satou et al. Oct 2005 B2
7004173 Sparks et al. Feb 2006 B2
7004176 Lau Feb 2006 B2
7056294 Khairkhahan et al. Jun 2006 B2
7131983 Murakami Nov 2006 B2
7137963 Nita et al. Nov 2006 B2
7149587 Wardle et al. Dec 2006 B2
7150853 Lee et al. Dec 2006 B2
7166098 Steward et al. Jan 2007 B1
7220233 Nita et al. May 2007 B2
7267650 Chow et al. Sep 2007 B2
7297131 Nita Nov 2007 B2
7335180 Nita et al. Feb 2008 B2
7341569 Soltani et al. Mar 2008 B2
7384407 Rodriguez et al. Jun 2008 B2
7393338 Nita Jul 2008 B2
7421900 Karasawa et al. Sep 2008 B2
7425198 Moehring et al. Sep 2008 B2
7494468 Rabiner et al. Feb 2009 B2
7503895 Rabiner et al. Mar 2009 B2
7540852 Nita Jun 2009 B2
7604608 Nita et al. Oct 2009 B2
7621902 Nita et al. Nov 2009 B2
7621929 Nita et al. Nov 2009 B2
7648478 Soltani et al. Jan 2010 B2
7771358 Moehring et al. Aug 2010 B2
7771452 Pal et al. Aug 2010 B2
7775994 Lockhart Aug 2010 B2
7776025 Bobo, Jr. Aug 2010 B2
7819013 Chan et al. Oct 2010 B2
7850623 Griffin et al. Dec 2010 B2
7918819 Karmarkar et al. Apr 2011 B2
7935108 Baxter et al. May 2011 B2
7938819 Kugler et al. May 2011 B2
7955293 Nita et al. Jun 2011 B2
8043251 Nita et al. Oct 2011 B2
8083727 Kugler et al. Dec 2011 B2
8133236 Nita Mar 2012 B2
8221343 Nita et al. Jul 2012 B2
8226566 Nita Jul 2012 B2
8246643 Nita Aug 2012 B2
8257378 O'Connor Sep 2012 B1
8308677 Nita et al. Nov 2012 B2
8414543 McGuckin, Jr. et al. Apr 2013 B2
8506519 Nita Aug 2013 B2
8613751 Nita et al. Dec 2013 B2
8617096 Nita et al. Dec 2013 B2
8632560 Pal et al. Jan 2014 B2
8647296 Moberg et al. Feb 2014 B2
8663259 Levine et al. Mar 2014 B2
8668709 Nita et al. Mar 2014 B2
8690818 Bennett et al. Apr 2014 B2
8690819 Nita et al. Apr 2014 B2
8764700 Zhang et al. Jul 2014 B2
8790291 Nita et al. Jul 2014 B2
8974446 Nguyen et al. Mar 2015 B2
9107590 Hansmann et al. Aug 2015 B2
9265520 Nita Feb 2016 B2
9282984 Nita Mar 2016 B2
9314258 Nita et al. Apr 2016 B2
9381027 Nita et al. Jul 2016 B2
9421024 Nita et al. Aug 2016 B2
9770250 Nita et al. Sep 2017 B2
10004520 Nita et al. Jun 2018 B2
20020022858 Demond Feb 2002 A1
20020029054 Rabiner et al. Mar 2002 A1
20020049409 Noda et al. Apr 2002 A1
20020077550 Rabiner et al. Jun 2002 A1
20020188276 Evans Dec 2002 A1
20030009153 Brisken et al. Jan 2003 A1
20030036705 Hare et al. Feb 2003 A1
20030040762 Dorros et al. Feb 2003 A1
20030176791 Rabiner et al. Sep 2003 A1
20030199817 Thompson et al. Oct 2003 A1
20030216732 Truckai et al. Nov 2003 A1
20030225332 Okada et al. Dec 2003 A1
20040024393 Nita et al. Feb 2004 A1
20040164030 Lowe et al. Aug 2004 A1
20040167511 Buehlmann Aug 2004 A1
20050033311 Guldfeldt et al. Feb 2005 A1
20050113688 Nita et al. May 2005 A1
20050149110 Wholey Jul 2005 A1
20050228286 Messerly et al. Oct 2005 A1
20060074441 McGuckin, Jr. Apr 2006 A1
20060206039 Wilson et al. Sep 2006 A1
20060264809 Hansmann et al. Nov 2006 A1
20070037119 Pal Feb 2007 A1
20080071343 Mayberry et al. Mar 2008 A1
20080208084 Horzewski et al. Aug 2008 A1
20080221506 Rodriguez et al. Sep 2008 A1
20090264770 Liu Oct 2009 A1
20100023037 Nita et al. Jan 2010 A1
20110105960 Wallace May 2011 A1
20110130834 Wilson et al. Jun 2011 A1
20110237982 Wallace Sep 2011 A1
20110313328 Nita Dec 2011 A1
20120130475 Shaw May 2012 A1
20120311844 Nita et al. Dec 2012 A1
20120330196 Nita Dec 2012 A1
20140236118 Unser et al. Aug 2014 A1
20140243712 Humayun et al. Aug 2014 A1
20150133918 Sachar May 2015 A1
20150150571 Nita et al. Jun 2015 A1
20150157443 Hauser et al. Jun 2015 A1
20150190660 Sarge et al. Jul 2015 A1
20150297258 Escudero et al. Oct 2015 A1
20150359651 Wübbeling Dec 2015 A1
20160128717 Nita May 2016 A1
20160183956 Nita Jun 2016 A1
20160271362 Van Liere Sep 2016 A1
20160338722 Nita et al. Nov 2016 A1
20170065288 Imai Mar 2017 A1
20170354428 Nita et al. Dec 2017 A1
Foreign Referenced Citations (68)
Number Date Country
2007240154 Jan 2008 AU
2256127 May 1974 DE
2438648 Feb 1976 DE
8910040 Dec 1989 DE
3821836 Jan 1990 DE
4042435 Feb 1994 DE
0005719 Dec 1979 EP
0316789 May 1989 EP
0316796 May 1989 EP
0376562 Jul 1990 EP
0379156 Jul 1990 EP
0394583 Oct 1990 EP
0443256 Aug 1991 EP
0472368 Feb 1992 EP
0541249 May 1993 EP
0820728 Jan 1998 EP
1323481 Jul 2003 EP
1106957 Mar 1968 GB
H2-7150 Oct 1988 JP
01-099547 Apr 1989 JP
6086822 Mar 1994 JP
H07500752 Jan 1995 JP
7116260 May 1995 JP
9-503137 Mar 1997 JP
10-216140 Aug 1998 JP
2000-291543 Oct 2000 JP
2001-104356 Apr 2001 JP
2001-321388 Nov 2001 JP
2002-186627 Jul 2002 JP
2005-253874 Sep 2005 JP
2006-522644 Oct 2006 JP
2007512087 May 2007 JP
2007520255 Jul 2007 JP
8705739 Sep 1987 WO
8705793 Oct 1987 WO
8906515 Jul 1989 WO
9001300 Feb 1990 WO
9004362 May 1990 WO
9107917 Jun 1991 WO
9211815 Jul 1992 WO
9308750 May 1993 WO
9316646 Sep 1993 WO
9412140 Jun 1994 WO
9414382 Jul 1994 WO
9508954 Apr 1995 WO
9509571 Apr 1995 WO
9515192 Jun 1995 WO
9635469 Nov 1996 WO
9705739 Feb 1997 WO
9721462 Jun 1997 WO
9745078 Dec 1997 WO
9827874 Jul 1998 WO
9835721 Aug 1998 WO
9851224 Nov 1998 WO
9852637 Nov 1998 WO
9925412 May 1999 WO
0053341 Sep 2000 WO
0067830 Nov 2000 WO
03039381 May 2003 WO
2004012609 Feb 2004 WO
2004093736 Nov 2004 WO
2004112888 Dec 2004 WO
2005053769 Jun 2005 WO
2006049593 May 2006 WO
2014022716 Feb 2014 WO
2014105754 Jul 2014 WO
WO2014105754 Jul 2014 WO
WO2016064077 Apr 2016 WO
Non-Patent Literature Citations (24)
Entry
Circulation Catheter-Based Ultrasound Thrombolysis Shake, Rattle, and Reperfuse Paul G. Yock, Peter J. Fitzgerald https://doi.org/10.1161/01.CIR.95.6.1360.
Japanese Office Action for Japanese Application No. 2010-134566, dated Mar. 2, 2012.
Sehgal, et al., Ultrasound-Assisted Thrombolysis, Investigative Radiology, 1993, vol. 28, Issue 10, pp. 939-943.
Siegel, et al., “In Vivo Ultrasound Arterial Recanalization of Atherosclerotic Total Occlusions”, Journal of the American College of Cardiology, Feb. 1990, vol. 15, No. 2, pp. 345-351.
“What is Electron Beam Curing?” downloaded from web on Nov. 14, 2002, 4 pages total. <http://www.ms.oml.gov/researchgroups/composites/new%20orccmt%20pages/pages/ebwha>.
Noone, D.: Experimental and Numerical Investigation of Wire Waveguides for Therapeutic Ultrasound Angioplasty. M.Eng. Dublin City University. 2008.
Definition of the term “connected”, retrieved on Sep. 21, 2013. <www.thefreedictionary.com/connected> 1 page total.
Supplemental European Search Report dated Nov. 5, 2009 for European Application No. EP03766931.
International Search Report dated Oct. 28, 2003 for PCT Application No. PCT/US2003/023468.
Extended European Search Report dated Mar. 22, 2012 for European Application No. EP11188799.
International Search Report dated Dec. 23, 2005 for PCT Application No. PCT/US2004/019378.
Extended European Search Report for Patent Application No. 06718204.8, dated May 30, 2012.
International Search Report dated Aug. 1, 2013 for PCT Application No. PCT/US2013/053306.
International Preliminary Report dated Aug. 1, 2013 for PCT Application No. PCT/US2013/053306.
Written Opinion dated Aug. 1, 2013 for PCT Application No. PCT/US2013/053306.
Supplemental European Search Report dated Apr. 29, 2009 for European Application No. EP 04711207.3.
Calhoun et al., “Electron-Beam Systems for Medical Device Sterilization”, downloaded from web on Oct. 8, 2002 <http://www.devicelink.com/mpb/archive/97/07/002.html> 7 pages total.
Definition of the term “coupled”, retrieved on May 18, 2013. <http://www.merriam-webster.com/dictionary/couple> 1 page total.
“E-Beam Theory” RDI-IBA Technology Group, downloaded from web on Oct. 8, 2002 <http://www.e-beamrdi/EbeamTheory.htm> 2 pages total.
Office Action dated May 20, 2010 from Japanese Application No. 2006-541200 filed on Oct. 25, 2004.
Office Action dated Oct. 11, 2012 from Japanese Application No. 2010-181956.
Extended European Search Report dated Mar. 5, 2012 for European Application No. 12153606.4-1269.
Margaret Fyfe et al., Mast cell degranulation and increased vascular permeability induced by ‘therapeutic’ ultrasound in the rate ankle joint, Br. J. exp. Path., 1984, vol. 65, pp. 671-676.
“Irradiation, Biological, and Other Technologies: E-beam, Biological, and Sharps Treatment Systems”, Non-Incineration Medical Waste Treatment Technologies, Aug. 2001, Chapter 9, pp. 69-74, Health Care Without Harm, Washington, DC.
Related Publications (1)
Number Date Country
20180177515 A1 Jun 2018 US